-
Hexvix-blue light cystoscopy article
http://www.medicalnewstoday.com/articles/77397.php
“A comparative study between GE Healthcare’s Hexvix® fluorescence cystoscopy and white light cystoscopy has shown that Hexvix® cystoscopy is more effective in the detection of Ta and T1 papillary lesions than white light1 cystoscopy alone in 29% patients. The study has been published in this month’s Journal of Urology issue.”
We’ve already seen that it’s usefulness in detecting CIS is confirmed (http://blcwebcafe.org/hexvix.asp), now this phase III trial reported by American experts is claiming it’s effectiveness at diagnosing more papillary tumors.
Very interesting.
I would think there is enough data now to get this tool approved for use in the US.
Wendy
Log in to reply.